Trading Strategies in Large-Cap Biotech Stocks

Patience in trading can lead to significant rewards, especially when targeting resilient large-cap biotech stocks.

### Navigating the Stock Market: Strategies for Biotech and Large-Cap Stocks
* 📈 Although there may be many dull days ahead, **patience in the market** is expected to yield rewards, especially after the **long holiday break**.
* 💼 My focus remains on the **domestic market**, despite my recent trading in U.S. stocks, with a particular interest in the **large-cap biotech sector** post-Chuseok holiday.
* 🔍 Targeting large-cap biopharmaceuticals like Alteogen is crucial, especially as it has recently **dropped below the golden line**, presenting a **safer trading opportunity** amidst market fluctuations.
* 💡 "A large bullish candle that pulls the market up significantly would be the ideal scenario," but caution is necessary as buying at peaks could lead to **losses if the market declines**.
* 📉 The trading volume in both U.S. and domestic markets has diminished, making it essential to **avoid impulsive purchases at high points** to prevent **unwanted losses**.
* 🚀 Stocks like Samsung Biologics and Hyundai Rotem show potential for recovery and **significant gains**, particularly if they **stabilize and break through key resistance levels**.
* 🔑 For stocks like Pharma Research and Daebong LS, closing **above critical price points** could indicate **further upward movement**, providing clear **opportunities for profit**.
* ⏳ Ultimately, focusing on **resilience and strategic entry points** in large-cap stocks can lead to successful trades, reinforcing the idea that "**those who are patient in the stock market tend to come out on top**."

Although there will be many boring days ahead as we continue to wait, it seems that the market will definitely reward us for our patience. This holiday feels particularly long, but since I have started trading U.S. stocks as well, it seems to have shortened the duration of the break. I can't help but think that perhaps I'm trading U.S. stocks to fill the void left by such a long holiday or my trading addiction. Regardless of what happens next year, my main focus will still be on the domestic market, so I hope there's no misunderstanding that I am completely moving away from the U.S. market. Now, I will summarize the stocks I am currently interested in. If we look at it by sector, large-cap biotech is still maintaining a strong trend, so my goal after the Chuseok holiday is to make profits in the biotech sector, as long as this strong trend continues.

If we think positively about the current situation, a large bullish candle that pulls the market up significantly would be the ideal scenario. However, given the current market sentiment, even if the market rises, it may do so in a frustrating manner. There's also the downside that if one buys at the peak, they might end up being stuck, as the market is ready to decline at any moment. Therefore, I believe that now is the time to target large-cap biopharmaceuticals, specifically Alteogen, especially when it has dropped below the golden line. This approach is a safer trading strategy. The moment it falls below the golden line could be an opportunity, and since such a strong trend typically has good resilience, rather than blindly enduring a situation where the future is unclear, one can make easier judgments based on this resilience. Additionally, the methods for making money can vary from market to market, and it's clear that over the past few months...

Until recently, it wasn't quite like this, but now the trading volume in the market has definitely dried up. Whether the U.S. market is rising or falling, the trading volume has clearly diminished. Therefore, what should absolutely be avoided right now is recklessly chasing after peaks or buying impulsively at the highest points, no matter how appealing they may seem. If you make purchases based on imagination, you could face unwanted losses and suffering due to a lack of liquidity. However, there is one advantage when trading volume dries up: attention can become concentrated in one place. For example, last week, Daebong LS experienced a long upper wick, resulting in a disappointing outcome that aligns with the current market characteristics. Still, when attention is focused, it can break through to new highs, as everyone participates in the market with the same mindset. If attention is properly concentrated in one area, it can lead to significant movements.

A great opportunity for making profits can definitely arise if you are careful about entering at the right moment. By setting your focus on specific stocks, particularly those that are hitting new highs or have recently seen significant trading activity, you can create good opportunities for yourself. These stocks are not finished until they are truly finished. If you wait for the desired reactions to occur, you will surely catch the fish on your fishing line. As always, those who are patient in the stock market tend to come out on top. 

The first stock to mention is Alteogen, which can be referred to as a zombie stock these days, alongside Samsung Biologics. As I mentioned, the best scenario would be for Alteogen to produce a large bullish candle, pushing it one step higher. Ideally, it would rise above 150,000 won, which would be the best case scenario. There are various strategies to consider, whether to trade short-term or otherwise.

If we can definitely break through the all-time high, and if it finishes strongly with a large bullish candle accompanied by significant trading volume, then entering at the closing price that day or at a later time can lead to a favorable pullback the next day. If luck is on our side, we could also benefit from a double large bullish candle. Therefore, what is needed in the current market is a clear situation. With a clear situation, we can also employ various strategies. Samsung Biologics is currently maintaining a good trend, and as the price stabilizes at this level, there is a potential for a historical all-time high to be reached over time. Although the stock price is currently below 1 million won, it wouldn’t be strange for it to rise to 1.1 million or 1.2 million won in a month or two. Hence, I am consistently monitoring Samsung Biologics as a stock of interest, looking for ways to approach it by assessing its recovery below the golden line or considering entering at this price level.

If it collapses to the point where there is absolutely no answer, and if it gets pushed below the golden line and cannot recover, of course, the expected losses will increase significantly. However, the current position has not deviated from the previous high and is well-established, so I believe it is a reasonable position to consider. Next, I occasionally check the stocks where the long-term trend is changing, and recently, HK Inno has completely changed its trend, resulting in beautiful charts on both the weekly and monthly scales. You can understand this by looking at Krafton; there are often times when a stock that has been declining suddenly changes its trend and then rises in a stair-step fashion, making it hard to tell where it will end. If we are really lucky and strong, there is still quite a distance to break through the complete high.

It may be greedy, but if luck is on our side, we might be able to touch the nearby levels and then trade again. Due to this trend, there is a potential for momentum that allows us to reach nearby touch points, especially since it is a newly listed stock. If we consider it similar to Krafton, there’s a chance we could touch close to the all-time high if luck permits. The trend is changing, and trading volume is starting to pick up. Although there aren’t any transactions in the market right now, I've categorized it for now.

Next, I reclassified Hyundai, which has recently been showing reactions in the market. It fell below the golden line but recovered relatively quickly. Once we confirm this recovery, it indicates that the stock price is solidifying. If it does solidify, as I mentioned earlier, we could expect a recovery when it breaks the golden line, and if you want something more certain, it might be better to...

Even if I cannot enter this position, it is not a bad idea to wait until it closes with a large bullish candle that has proper trading volume. Moreover, since we are near the 50,000 won mark, if it gets pressed down during the day and trades around that level, I believe I can withstand a slight pullback near 50,000 won, as I see it as a place with a decent risk-reward ratio. If it continues to hit new highs without collapsing, there could be repeated stair-step increases. Therefore, I am continuously monitoring Hyundai Rotem. 

Next is Pharma Research. Recently, there was some reaction, but on September 11, there was a somewhat disappointing bearish candle. However, I believe it is crucial for it to close above 190,000 won. It recently broke through to a new high; September 6 was similar, as was September 11, when it was supported up to 200,000 won.

The closing price has not been able to break through 190,000 won. The sharpest timing is such that it doesn’t matter if you buy at a higher price; if it finishes distinctly above 190,000 won, then I believe there could be a medium-term stair-step rise in the stock price. This would create a sharp entry point. Even if the price fluctuates up and down during the day, I wouldn't necessarily enter, but if the closing price ends well, then we should consider a strategy for buying at the closing price or using a time unit. 

Next, regarding Daebong LS with an upper shadow, even if it has an upper shadow, as long as the trading volume is alive, it’s not over until it’s over. Similarly, if we judge based on the closing price, it can be easy to trade. If it closes above 2,850 won, then there might be further opportunities the next day.

A position can easily arise. It's important to make quick gains, so if we can wrap things up around this position, we may find opportunities for a rebound the next day or even a double long candle where we can take profits easily. It can also be viewed as a position where we can trade on a pullback from the bottom. However, since the market capitalization of this stock is not that large, unlike others with a market cap in the trillions, we should only take short-term gains in clear situations. Next is Yuhan Corporation, where the trend is still being maintained. Recently, it has been declining continuously, but the trends of large biotech stocks and Yuhan Corporation are still decent. If it falls below the golden line, then...

It seems that we can assess based on resilience. If there is a pullback, we should observe whether recovery occurs within three trading days. If recovery happens, we can take profits corresponding to that recovery. For example, if we break the golden line and finish there, we could enter at the closing price that day, and if the resilience looks good, we could take a short profit based on that recovery. Alternatively, after the recovery, we might aim for a bit more profit with expectations of additional upward movement. 

To summarize my two representative trading strategies: in large-cap stocks, when trading volume based on resilience is below the golden line, if a strong bullish candle that can pull all the money into the market appears, like on August 28th with YuHan Pharmaceutical, the next day, no matter what, it is likely to rebound effectively. If we are lucky, we might even capture a double bullish candle. This is a definite situation.

If you focus on just two main factors when trading, it seems possible to trade without significant risks. Although there will be many boring days ahead as you continue to wait, the market surely rewards you for the time you spend waiting.

현재 인기 관심주 모든 돈이 몰린다

안녕하세요. 창원개미TV입니다. 저는 오직 유튜브에서만 활동합니다. 사칭으로 인한 피해 조심하시기 바랍니다. 
사적인 제안이나 유료광고는 받지 않습니다.
실전투자에서 겪은 경험을 토대로 최대한 좋은영상을 제공해드리기 위해서 노력하고있습니다. 숨김과 거짓없이 초심그대로 최대한 성실하게 방송하겠습니다.

창원개미TV

Navigating the Stock Market During a Long Holiday

The long holiday has been tedious, but trading U.

The focus remains on the domestic market, with a strong interest in large-cap biotech for profit after the holiday.

The current market sentiment is cautious, with a diminishing trading volume, making it crucial to avoid impulsive buying and instead target resilient stocks like Alteogen.

Careful timing and focusing on specific stocks hitting new highs can create profitable opportunities.

Alteogen and Samsung Biologics are highlighted as key stocks to watch, with potential for significant price increases.

Monitoring long-term trend changes in stocks like HK Inno and Krafton can also lead to favorable investment opportunities.

Trading Insights on Newly Listed Stocks and Hyundai

There is potential for momentum in a newly listed stock, with the possibility of reaching nearby touch points and all-time highs.

Hyundai's stock has shown a quick recovery after falling below the golden line, and a solidification of its price could lead to a recovery and bullish movement.

Pharma Research's stock needs to close above 190,000 won for a positive outlook, with recent support levels indicating potential for further growth.

Stock Price Analysis and Trading Strategy

The closing price has struggled to break 190,000 won, with a potential medium-term rise if it finishes above that level.

Daebong LS, despite having an upper shadow, may offer trading opportunities if it closes above 2,850 won.

Yuhan Corporation's trend remains decent, but a fall below the golden line could indicate a change in momentum.

Assessing resilience is key in trading, with a focus on recovery within three days after a pullback.

Profits can be taken from the recovery, with the potential for additional gains from upward movement.

Two main strategies involve trading large-cap stocks with strong bullish candles and waiting for effective rebounds, aiming to minimize risks.